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Abstract: Given a global focus on salt reduction efforts to reduce cardiovascular risk, it is important to
obtain accurate measures of salt intake on a population level. This study determined firstly whether
adjustment for intra-individual variation in urinary sodium (Na) excretion using three repeated
24 h collections affects daily estimates and whether the use of repeated spot urine samples results in
better prediction of 24 h Na compared to a single collection. Twenty three community-dwelling men
and women from South Africa (mean age 59.7 years (SD = 15.6)) participating in the World Health
Organization Study on global AGEing and adult health (WHO-SAGE) Wave 3 study collected 24 h
and spot early morning urine samples over three consecutive days to assess urinary Na excretion.
INTERSALT, Tanaka, and Kawasaki prediction equations, with either average or adjusted spot
Na values, were used to estimate 24 h Na and compared these against measured 24 h urinary Na.
Adjustment was performed by using the ratio of between-person (sb) and total (sobs) variability
obtained from repeated measures analysis of variance. Sensitivity of the equations to predict daily
urinary Na values below 5 g salt equivalent was calculated. The sb/sobs for urinary Na using
three repeated samples for spot and 24 h samples were 0.706 and 0.798, respectively. Correction
using analysis of variance for 3 × 24 h collections resulted in contraction of the upper end of the
distribution curve (90th centile: 157 to 136 mmoL/day; 95th centile: 220 to 178 mmoL/day). All three
prediction equations grossly over-estimated 24 h urinary Na excretion, regardless of whether a single
spot urine or repeated collections corrected for intra-individual variation were used. Sensitivity of
equations to detect salt intake equivalent values of ≤5 g/day was 13% for INTERSALT, while the
other two equations had zero sensitivity. Correcting for intra-individual variability in Na excretion
using three 24 h urine collections contracted the distribution curve for high intakes. Repeated
collection of spot samples for urinary Na analysis does not improve the accuracy of predicting 24 h
Na excretion. Spot urine samples are not appropriate to detect participants with salt intakes below
the recommended 5 g/day.
Keywords: sodium; salt; urinary excretion; spot urine; equations; variability; sensitivity
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1. Introduction
Many leading medical and public health organizations recommend reducing dietary sodium (Na)
to a maximum of 2000 mg per day (5 g salt) [1] on the basis of evidence indicating a public health
benefit [2]. There is strong evidence of a linear, dose–response effect of sodium reduction on blood
pressure (BP) [3]. In addition, the evidence shows that sodium reduction prevents cardiovascular
disease [4].
In order to monitor the effectiveness of salt reduction strategies on a population level, it is important
to collect regular and representative indicators of habitual salt intake. Multiple, non-consecutive,
24 h urine collections are the gold standard for assessing sodium intake [5,6]. Using the method of
repeated 24 h urine collections over 1.5 to 4 years, the Trials of Hypertension Prevention (TOHP) study
demonstrated a linear 17% increase in cardiovascular disease risk per 1000 mg/day increase in sodium,
from levels starting as low as 1500 mg/day among 2275 participants [7].
However, the high burden of labour and difficulty to collect complete 24 h urine samples has
prompted the search for more practical alternative methods, such as spot urinary Na concentrations.
For this purpose, a number of prediction equations that include spot Na and creatinine concentrations
have been developed by multiple research groups. Of these, the most commonly used are
INTERSALT [8], Kawasaki [9], and Tanaka [10]. These equations have been validated against
24 h urinary sodium excretion, but mostly in American or Japanese populations. Authors have reported
that these equations unacceptably overestimate individual intake at low levels and underestimate
intake at high levels, even while being unbiased at the average level [5,11].
Collection of 24 h urine samples is particularly onerous in low-middle income countries (LMICs)
where poor infrastructure exists for transport and laboratory services, especially in rural areas.
The application of equations to spot urine samples in order to estimate 24 h excretion concentrations
has been used in some large observational studies in LMICs, such as the Prospective Urban Rural
Epidemiology (PURE) study [12], but this has raised much criticism [13,14] regarding potentially
erroneous conclusions on the association between salt intake and cardiovascular disease outcomes.
We have previously reported that equations using spot urine collections have an unacceptably wide
degree of bias and are not appropriate for use in the South African population with Tanaka, Kawasaki,
and Mage equations—all overestimating salt intake (15). The INTERSALT equation systematically
underestimated measured 24 h sodium excretion [15]. Other authors have reported similar findings [16].
Intraperson variability in sodium intake can be as great or greater than interpersonal variability
due to the varied nature of food intake from day-to-day [5,17]. Because of measurement challenges
and day-to-day variability in sodium intake, estimating population averages is subject to far less error
than estimating individual intake. A method to reduce or remove the effects of measurement error
due to intra-individual variation would allow a more accurate description of habitual salt intake.
Several methods exist to correct for intra-individual variation in population surveys. One method is to
collect multiple collections for each participant and average their data. Another method is to apply a
correction factor to the distribution [18,19]. This requires estimating the correction factor, for example,
by collecting multiple samples from a representative subset of the survey population. The correction
method has been applied many times to dietary intake data [20–22] but less frequently to biochemical
data [23–25]. We have previously applied this method to spot urinary iodine concentrations (UIC) in a
sample of older Australians and found that it narrowed the extremes of UIC at the upper end of the
curve [26].
As a population reduces salt intake, accurate estimation becomes more important for refining
intervention efforts and monitoring success [27,28]. The objective of this study was to evaluate the
impact of collecting three consecutive repeated 24 h samples for calculating the correction factor for
urinary Na excretion and comparing this with the effect of averaging the results for each person. It also
assesses whether the use of three repeated spot samples to correct spot urinary Na concentrations in
prediction equations improves the sensitivity and specificity to classify individuals with salt intakes
above and below the recommended 5 g salt/day cut off.
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2. Materials and Methods
Data was collected in a sub sample of participants included in the Salt and Tobacco World Health
Organization Study on global AGEing and adult health (WHO-SAGE) study in South Africa. SAGE is
a multinational study examining the health and well-being of adult populations and the ageing
process [29]. Evaluation of the health effects of the mandatory salt reduction policy [30] on South
African adults is being conducted using a nested study design in waves 2 and 3 [31]. Inclusion criteria
for urine collection were: respondent must be part of the WHO-SAGE cohort, with no indication of
urinary incontinence or another condition that could impede 24 h urine collection; and if female, not
menstruating, pregnant, or breast feeding on the day of collection.
Survey teams were trained with support from WHO Geneva, with survey teams using standardised
household, individual, and proxy questionnaires, anthropometry, blood sampling, BP, and physical
function tests as described previously in SAGE wave 1 [29]. The study protocol used for sodium
determination in 24 h urine samples followed the WHO/Pan American Health Organization (PAHO)
guidelines [27]. Respondents were requested to collect all urine produced for 24 h, excluding the first
pass urine on day 1, but including the first urine of the following morning (day 2) in a 5 L plastic
container using 1 g thymol as a preservative. Spot samples were collected without preservative from
the second urine passed on day 1 (marking the start of the 24 h collection) and decanted into three
15 mL Porvair tubes (Porvair Sciences, Leatherhead, UK), then kept in a thermoelectric cooler box
powered by the fieldwork vehicles and containing ice packs to maintain a lowered temperature. Early
morning rather than random samples were collected for spot samples due to logistics of the fieldwork
and because of the evidence that early morning samples more closely reflect diurnal variation [32,33].
Each 24 h sample was collected the next morning, total volumes were recorded, and aliquots generated
with all samples then shipped to the laboratory, maintaining the cold chain using precooled ice packs
as a means to maintain temperature control. When the samples arrived at the laboratory, the cooler
box was examined and the temperature of the samples noted and recorded. Thymol preservative,
a crystalline natural derivative of the thyme plant, has been shown not to affect urinary creatinine,
sodium, or potassium concentrations for up to 5 days after collection at room temperature [34].
Incomplete 24 h urine collections were assumed if: total volume <300 mL; or creatinine excretion
<4 mmoL/day (women) or <6 mmoL/day (men) [35]. Sodium was determined using the indirect
ion-selective electrode method and creatinine analysed using the standardised urinary Jaffe kinetic
method (Beckman Coulter Synchron DXC600/800 System). For BP measurements, validated wrist-worn
Omron BP devices (R6, Omron, Japan) [34] were used to record three sequential measures on the left
arm (1 min between each measure and following 5 min at rest). The participant held their wrist directly
at the level of the heart using inbuilt positional sensors in the device and was seated with legs uncrossed
throughout the measurements. The mean of the second and third readings were used to generate a
blood pressure value. Blood pressure values were deemed as valid if: Systolic (Sys) > Diastolic (Diast);
80 ≤ Sys ≤ 270 mmHg; 40 ≤ Diast ≤ 180 mmHg; and pulse pressure (Sys-Diast) ≥ 13 [36].
Statistical Analysis
Data were transformed using the natural logarithm to improve normality. Repeated measures
analysis of variance was performed to determine the between person (sb) and total (sobs)
variability [18,19]. An adjusted log Na (for spot and 24 h) value was calculated for each person
as: Adjusted Na (spot or 24 h) = ((person’s day 1 Na− group mean for day 1) × (sb/sobs)) + group
mean for day 1.
The results were exponentiated. First, the correction factor (sb/sobs) was calculated using only
the first two replicates, then it was calculated using all three replicates. This was done for spot Na
measures (mmoL/L) and also for 24 h Na concentrations (mmoL/day). The average for each person
was calculated using the first two day replicates and for all three days. Centiles of the distribution
were calculated for the raw day 1 data and for distributions derived using adjustment or averaging.
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In order to compare urinary Na estimates between spot and 24 h collections, the INTERSALT,
Tanaka, and Kawasaki equations were applied to spot Na values, using single, 2 day average, 3 day
average, and 2 and 3 day corrected values in the equations. In the case of Tanaka and Kawasaki
equations, spot creatinine was similarly averaged or adjusted (Supplementary Materials Table S1).
The resultant predicted 24 h values were compared with the first 24 h Na collection. Correlations
were conducted by Spearman coefficients and the sensitivity of the predicted proportion below and
above 5 g salt per day estimated. Wilcoxon signed rank test was applied to test the difference between
measured 24 h Na to the estimation obtained by the implementation of the three different equations.
Analyses were performed using STATA SE, version 12.1 (Stata Statistical Software: Release 12. College
Station, StataCorp LP, TX, USA).
SAGE was approved by the WHO Ethics Review Committee (reference number RPC149) with
local approval from the North-West University Human Research Ethics Committee and University of
the Witwatersrand Human Research Ethics Committee. All respondents provided written informed
consent prior to taking part in the study. The study complies with the ethical principles for medical
research involving human participants as per the Declaration of Helsinki.
3. Results
Of the 48 participants who collected repeated urine samples, only 23 had three days of valid
collections and were thus included in the analysis. These were all from the same ethnic background
(African/Black). Descriptive data is presented as median (IQR) because of non normal distributions.
Background characteristics are shown in Table 1, while the median Na, K, and Cr values in spot and
24 h urine, by collection day, are reported in Table 2.
Table 1. Sample demographic and clinical characteristics.
Characteristics All Subjects(n = 43)
Subjects with 3-Days Valid
Measurements (n = 23)
Sex, n (%)
Women 31 (72.1) 16 (69.6)
Men 12 (27.9) 7 (30.4)
Age (years) 62 (19) 58 (18)
BMI (Kg/m2) 30.1 (9.3) 33.8 (9.6)
Normal weight (18.5–24.9 kg/m2), n (%) 8 (18.6) 1 (4.3)
Overweight (25–30 kg/m2), n (%) 12 (27.9) 6 (26.1)
Obese (≥30 kg/m2), n (%) 23 (53.5) 16 (69.6)
Systolic BP (mm Hg) 140 (40) 133 (41)
Diastolic BP (mm Hg) 88 (27) 88 (26)
BMI: Body Mass Index, BP: Blood Pressure. For the total sample (n = 43) and for the sample with 3-days valid
measurements (n = 23), data are presented as median (IQR), unless otherwise indicated.
Table 2. Spot and 24 h urinary Na, K, and Cr, by collection day.
Characteristics Day 1 (n = 23) Day 2 (n = 23) Day 3 (n = 23)
Spot Na (mmoL/L) 89.0 (59.0) 90.0 (52.0) 80.0 (70.0)
Spot K (mmoL/L) 26.7 (14.4) 32.0 (35.5) 22.0 (23.4)
Spot Cr (mmoL/L) 9.7 (8.5) 9.6 (6.8) 7.3 (5.3)
24 h urine volume (ml) 1100.0 (580.0) 1100.0 (995.0) 1200.0 (700.0)
24 h Na (mmoL/day) 107.0 (88.0) 95.0 (45.0) 80.0 (84.0)
24 h K (mmoL/day) 33.9 (22.5) 27.3 (24.1) 27.5 (21.8)
24 h Cr (mmoL/day) 9.9 (8.3) 8.3 (8.4) 9.9 (9.1)
Na: sodium, K: potassium, Cr: creatinine. For each day of collections and for each compound, data are presented as
median (IQR).
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3.1. Distribution of Repeated Spot and 24 h Urinary Na Concentrations
The distribution of spot and 24 h urinary Na concentration is shown in Table 3, according to raw
data from Day 1 only, after correction for intra-individual variation of two and three spot sample
collections and for averages of multiple collections. This is graphically represented for spot and 24 h
urinary Na concentrations in Figure 1; Figure 2, respectively.
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Figure 1. Population distribution of urinary spot Na (mmoL/L), according to number of days of
urine collection (n = 23). Density refers to proportion of persons, e.g. 0.005 = 0.5%). Solid line:
raw data from day1 only; thin dashed line: after correction for average of day1 and day2; thick dashed
line after correction for intra-individual variation of day1 and day2; thin long dashed & dotted line:
after correction for average of all three days; thick long dashed & dotted line after correction for
intra-individual variation of all three days.
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Figure 2. Population distribution of 24 h urinary Na (mmoL/day), according to number of days of
urine collection (n = 23). Density refers to proportion of persons, e.g. 0.002 = 0.2%). Solid line:
raw data from day1 only; thin dashed line: after correction for average of day1 and day2; thick dashed
line after correction for intra-individual variation of day1 and day2; thin long ashed & dotted line:
after correction for average of all three days; thick lo g dashed & d tted line aft r corr c i n for
intra-individual variation of all three days. Vertical dashed lines correspond to 5 g salt/day (equivalent
to 87 mmoL/day).
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Despite the median being similar for Day 1 and corrected 3-day values for 24 h samples, the upper
end of the distribution was contracted (90th (p90) and 95th (p95) percentile reduced from 201 and 220
mmoL/day, respectively, to 170 and 182 mmoL/day) (Table 3). In the case of spot urinary Na, correction
for 3 days reduced the p90 and p95 from 163 and 186, respectively, to 125 and 135 mmoL/L, respectively.
The proportion of participants categorised as having salt intake equivalents ≤5g/day, according to a
single sample, was 39.1%, which remained the same for an average of days 1 and 2, as well as values
adjusted for either days 1 and 2 or adjusted for all 3 days, but was slightly lower when all 3 days were
averaged (34.8%).
Spearman’s correlations for log-transformed urinary 24 h Na (mmoL/day) concentration values
were: days 1 and 2: r = 0.80, p < 0.0001; days 1 and 3: r = 0.53, p = 0.0086; days 2 and 3: r = 0.55,
p = 0.0060. While the correlations for log-transformed urinary spot Na (mmoL/L) concentration values
were: days 1 and 2: r = 0.29, p = 0.1812; days 1 and 3: r = 0.52, p = 0.0117; days 2 and 3: r = 0.44,
p = 0.0364. Similarly, spot potassium (K) and creatinine (Cr) urinary concentration distribution is
shown according to raw data collected on day 1 and after adjustment for intra-individual variation of
two and three spot sample collections and averages of multiple collections in Supplementary Table S1.
Table 3. Spot and 24 h Na urinary concentration distribution, raw data from day 1, after correction for












Minimum 14.00 23.50 21.71 35.00 27.79
p5 a 44.00 36.00 51.33 39.00 55.99
p10 45.00 54.50 52.21 49.00 56.76
p25 60.00 71.50 64.81 66.33 67.69
p50 89.00 92.00 87.16 85.33 86.14
p75 119.00 107.50 108.43 112.67 102.89
p90 163.00 136.00 137.36 150.67 124.73
p95 186.00 152.00 151.68 162.33 135.21
IQR 59.00 36.00 43.62 46.33 35.21
Maximum 193.00 186.50 155.95 179.00 138.30
Mean 93.30 93.35 88.36 92.86 86.19
SD 45.66 35.57 33.04 36.11 26.59
24 h Na (mmoL/day)
Minimum 32.00 38.00 37.15 38.67 42.60
p5 49.00 42.50 53.84 41.67 58.70
p10 56.00 46.00 60.48 48.00 64.90
p25 66.00 71.00 69.78 68.67 73.44
p50 107.00 107.00 106.29 110.67 105.64
p75 154.00 130.50 145.95 141.33 138.93
p90 201.00 195.50 184.05 172.33 169.76
p95 220.00 202.50 199.11 213.00 181.69
IQR 88.00 59.50 76.17 72.67 65.49
Maximum 232.00 227.00 208.54 227.00 189.10
Mean 115.00 107.87 111.71 109.22 109.12
SD 56.33 50.77 48.09 50.54 40.92
a p = percentile. Na: sodium. The intra-individual variation (sb/sobs) was, respectively, for spot and 24 h Na: 0.752
and 0.871 when calculated using two replicates and 0.612 and 0.752 when calculated using three replicates.
3.2. Prediction Equations to Estimate 24 h Na from Spot Na
Of the three prediction equations, the INTERSALT prediction equation most closely approximated
measured 24 h Na excretion (day 1), however values were still grossly over-estimated (Table 4).
Compared to a median 24 h Na excretion of 107 mmoL/day, using a single (Day 1) spot urine value in
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the equation resulted in an estimate of 133–141 mmoL/day, which was similar regardless of whether
the average of 2 or 3 repeated spot concentrations was used in the equation or whether correction
factors for intra-individual variability were applied.
Table 4. Prediction equations to estimate 24 h Na using correction applied for both spot Na and spot Cr





















Minimum 32.00 4.48 12.06 11.00 14.21 12.27
p5 49.00 21.09 39.03 42.41 48.53 45.41
p10 56.00 90.52 102.67 105.63 109.21 106.67
p25 66.00 132.82 119.21 122.35 120.76 122.20
p50 107.00 140.74 132.96 141.44 133.02 141.39
p75 154.00 167.67 164.70 164.97 172.34 165.93
p90 201.00 212.32 209.14 208.46 198.68 204.26
p95 220.00 215.77 209.20 213.71 207.71 206.18
IQR 88.00 34.85 45.48 42.62 51.57 43.74
Maximum 232.00 220.26 215.19 214.36 228.70 213.41
Mean 115.00 140.87 140.17 142.80 140.58 142.15
SD 56.33 51.30 49.01 48.10 47.86 47.01
p-value * 0.0208 0.0150 0.0150 0.0177 0.0163
Spearman r 0.3083 0.2856 0.2727 0.2885 0.2579
p-value 0.1524 0.1865 0.2080 0.1818 0.2348
* p-value of difference between measured 24 h urinary sodium excretion and each prediction equation using
INTERSALT was assessed by Wilcoxon’s signed rank test. Na: sodium, Cr: creatinine.
The sensitivity of the INTERSALT equations to classify subjects according to 24 h Na excretion
equivalent to ≤5 g salt per day was 11.1%, while the specificity (classification of intakes >5 g salt
equivalent/day) was 92.9%. Sensitivity and specificity remained the same within all five estimates
(single day, mean, or corrected values for days 1 and 2 or for all 3 days). Using a single spot sample in
the INTERSALT equation resulted in 52% subjects having a relative difference of >40% compared to
measured 24 h Na and only 4.4% subjects within 10%. The relative difference >40% or <10% for the
other values were, respectively, 56.5% and 13.0% for mean days 1 and 2; 60.9% and 8.7% for adjusted
days 1 and 2; 56.5% and 4.4% for the mean value of all 3 days; and 60.9% and 8.7% for adjusted for all
3 days (data not shown).
Using the INTERSALT equation, compared to day 1 for 24 h urine collection, the proportion of
participants with salt equivalent intakes ≤5 g/day (39.1%) was 8.7% for spot day 1 alone and this
remained unchanged for any further day collections, expressed either as averages or adjusted values
over 2 or 3 days.
Both Tanaka (Table 5) and Kawasaki (Table 6) equations performed poorly, whether a single
(Day 1) spot sample was used or means and adjusted variations of 2 and 3 day collections, with zero
sensitivity (no subjects classified as ≤5 g salt equivalent/day) and specificity of 100% for >5 g salt/day
across all iterations. In other words, neither equation categorised any participants as having salt intake
equivalents of ≤5 g/day. Using the Tanaka equations, 95.7% of subjects were classified as having >40%
difference between measured and predicted 24 h Na excretion, regardless of whether single or repeated
spot urinary Na concentrations (corrected or averaged) were used in the equations. Whereas when
the Kawasaki equation was applied, all subjects were classified as having >40% difference between
measured and predicted 24 h Na excretion.
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Table 5. Prediction equations to estimate 24 h Na using correction applied for both spot Na and spot Cr





















Minimum 32.00 124.32 176.45 182.74 227.93 204.29
p5 49.00 207.34 225.89 231.07 244.95 236.30
p10 56.00 238.77 236.59 287.05 245.80 293.09
p25 66.00 285.11 283.61 325.21 276.53 332.74
p50 107.00 396.58 370.48 374.39 370.83 377.85
p75 154.00 482.93 415.18 438.87 431.25 419.99
p90 201.00 559.35 485.55 478.08 461.72 458.77
p95 220.00 572.75 500.06 498.03 477.71 478.86
IQR 88.00 197.82 131.56 113.66 154.72 87.25
Maximum 232.00 738.90 597.13 541.18 498.26 522.32
Mean 115.00 392.03 364.27 376.83 364.58 374.55
SD 56.33 138.88 97.35 84.72 83.76 74.80




0.1047 0.3192 0.1808 0.2372 0.1927
p-value
correlation 0.6343 0.1377 0.4090 0.2759 0.3784
* p-value of difference between measured 24 h urinary sodium excretion and each prediction equation using Tanaka
was assessed by Wilcoxon’s signed rank test. Na: sodium, Cr: creatinine.
Table 6. Prediction equations to estimate 24 h Na using correction applied for both spot Na and spot Cr





















Minimum 32.00 130.04 203.27 212.56 281.76 245.04
p5 49.00 288.74 341.67 331.53 357.15 341.13
p10 56.00 349.23 373.04 403.65 366.99 422.93
p25 66.00 445.93 428.95 524.98 415.92 526.37
p50 107.00 680.59 615.32 685.76 620.88 671.39
p75 154.00 913.44 838.75 824.38 834.91 791.88
p90 201.00 1033.24 939.30 907.04 990.56 904.10
p95 220.00 1060.30 940.61 961.78 1001.26 953.36
IQR 88.00 467.50 409.79 299.39 418.99 265.51
Maximum 232.00 1360.01 975.35 1102.78 1013.84 1048.92
Mean 115.00 693.41 633.74 660.08 635.66 654.93
SD 56.33 290.66 227.94 210.98 223.79 198.86




0.1650 0.3192 0.2292 0.2806 0.2085
p-value
correlation 0.4518 01377 0.2927 0.1946 0.3397
* p-value of difference between measured 24 h urinary sodium excretion and each prediction equation using
Kawasaki was assessed by Wilcoxon’s signed rank test. Na: sodium, Cr: creatinine.
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4. Discussion
In a sample of older South African adults, correcting for intra-individual variability in daily salt
intake using three repeated 24 h urine collections did not alter median Na values but did contract the
upper tail of the distribution curve to result in lower values in the uppermost percentiles. The similarity
of 24 h Na excretion across three days of urine collection in the current study may reflect a less varied
diet than that reported in other populations.
To our knowledge, this is the first study to consider whether repeated spot urine collections could
improve the validity of prediction equations to estimate 24 h salt intake. We have confirmed that the
use of three repeated spot urinary Na concentrations, corrected for intra-individual variability, did not
result in more accurate predicted 24 h Na excretion values. Our data does not support the use of either
a single or two or three repeated spot urinary Na concentrations to estimate habitual salt intake. Of the
three prediction equations applied to the dataset, all grossly over estimated 24 h urinary Na excretion,
with INTERSALT performing somewhat better.
Many studies have shown that spot urine samples have limited applicability in determining 24 h
salt intake at a population level. In our study, all spot collections were taken as early morning samples,
as has been done in another validation study that found three repeated early morning spot samples
most closely approximated 24 h urinary Na collections [37]. However, other studies have reported that
higher numbers of repeated spot urine collections, ranging from four to seven collected at random,
improved accuracy of estimates of repeated 24 h urinary excretions [38,39]. A validation study in
Chinese adults found that all three equations (Kawasaki, INTERSALT, and Tanaka) performed poorly
in estimating 24 h urinary sodium excretion [40]. In that study, the Kawasaki formula provided the least
biased estimate of sodium intakes, while the INTERSALT formula showed the largest bias. The PURE
(Prospective Urban Rural Epidemiology)-China Study reported similar findings [41]. However, in the
current study, the INTERSALT equations provided the least-biased information, as was reported in an
American population aged 18–39 years [32].
The Kawasaki and Tanaka formulae were originally developed in Japanese populations [9,10] that
have very high salt intakes, whereas the INTERSALT formula was based on Western populations [8].
The finding that the Kawasaki equation provided estimates six times that 24 h urinary Na excretion is in
contrast to other research [42], which suggests that while spot urine estimates under- and over-estimate
actual excretion at extremes of the range, mean levels are relatively close. Another study from South
Africa reported a lower magnitude of error but similarly reported the greatest bias with the Kawasaki
equation and least with the INTERSALT equation [16]. Conflicting findings may thus be due to
differences in dietary patterns and confounding factors associated with ethnicity, culture, cuisine,
as well as differences in body size and composition. One study by Nguyen et al. (2019) applied the
Tanaka formula to annual urine spot samples taken in Japanese workers (n = 4360) over a five year
period [43]. They showed that for each SD increase in estimated 24 h sodium, there were small but
significant increases in both systolic and diastolic BP. Many studies have confirmed the relationship
between vascular health and Na intake, including those with ultra-precise methodology such as
long-term Na balance studies [44]. A highly controlled study suggested that compared to a single
24 h collection, three consecutive 24 h urine collections improved the precision to predict dietary
Na intake from 49% to 75% accuracy and for K from 66% to 81% accuracy [45]. While the results
obtained at controlled fixed intakes can demonstrate inherent variability in the measures, they are not
reflective of people’s daily lives, which introduce further variability from differences in daily food
intakes, hydration status, temperature, humidity, and exercise levels. As such, even multiple 24 h urine
collections are likely to be, at best, an estimate of habitual intake, albeit with a greater level of accuracy.
Previous research has suggested that up to 10 repeated 24 h urine samples may be required for an
accurate estimate of usual sodium intake [46,47]. Given this and the many publications in the literature
using sodium estimates from spot urine samples, interpretation of the findings of such studies should
be viewed with caution. Given the older age group and overall low 24 h Na excretion, generalizability
to wider age groups that may have more diverse dietary patterns is limited.
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Our study is limited by a small sample size, yet we successfully obtained both 24 h and spot urine
samples in a consistent manner. These samples allowed unique comparisons of intra-individual 24 h
Na and spot Na concentrations over 3 days and the accuracy in using different formulae to determine
daily salt intake in a general population sample with similar habits and within the same region.
5. Conclusions
Accurate measurement of population-level salt intake is required to monitor progress toward
salt-reduction targets, but collection of 24 h urine samples to analyse Na is burdensome. Spot urine
collections, proposed as a proxy for assessing 24 h Na excretion using prediction equations, are not
valid for use in an urban older obese population in South Africa. Correction for intra-individual
variability using three repeated spot urine collections did not improve validity, nor sensitivity in
characterizing individuals with low salt intakes. The use of three repeated 24 h urinary Na collections
resulted in a shrinkage of population distribution at the upper extremes but did not impact on overall
assessment of the median. This data suggests that a single 24 h urinary Na collection is appropriate for
use in population surveys to detect habitual salt intake.
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estimate 24 h Na, converted to salt equivalent (g/day) using correction applied for both spot Na and spot Cr using
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